Yaqi Lv
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 1%
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Surgery 5
- Hemodynamic Monitoring and Therapy 3
- Co-authors
- Lifang Yin (13 shared papers)Yiao Wang (3 shared papers)Lifang Fan (2 shared papers)Wei He (1 shared paper)Jin Zhu (1 shared paper)Chao Qin (1 shared paper)Ke Yang (1 shared paper)Shumin Zhu (1 shared paper)
- Journals
- International Journal of Pharmaceutics (5 papers)Scientific Reports (2 papers)BMC Medical Research Methodology (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Journal of Materials Chemistry B (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yaqi Lv
25 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Pharmaceutical Science 393
- Drug Discovery 7
- Biomaterials 473
- Molecular Medicine 77
- Pharmacology 78
Countries citing papers authored by Yaqi Lv
This map shows the geographic impact of Yaqi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqi Lv more than expected).
Fields of papers citing papers by Yaqi Lv
This network shows the impact of papers produced by Yaqi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqi Lv. The network helps show where Yaqi Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaqi Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International Journal of Pharmaceutics Hit paper breakdown → | 2015 | 986 |
| 2 | 2018 | 207 | |
| 3 | 2017 | 78 | |
| 4 | 2018 | 71 | |
| 5 | 2014 | 67 | |
| 6 | 2017 | 52 | |
| 7 | 2016 | 47 | |
| 8 | 2015 | 46 | |
| 9 | 2015 | 25 | |
| 10 | 2015 | 23 | |
| 11 | 2020 | 20 | |
| 12 | 2018 | 20 | |
| 13 | 2017 | 18 | |
| 14 | 2016 | 17 | |
| 15 | 2014 | 13 | |
| 16 | 2017 | 11 | |
| 17 | 2014 | 11 | |
| 18 | 2016 | 11 | |
| 19 | 2018 | 10 | |
| 20 | 2018 | 9 |
About Yaqi Lv
Yaqi Lv is a scholar working on Biomaterials, Surgery, Molecular Biology, Biomedical Engineering and Physiology, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Clinical Laboratory Practices and Quality Control (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers), Hemodynamic Monitoring and Therapy (3 papers), Advanced Drug Delivery Systems (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (393 citations), Drug Discovery (7 citations), Biomaterials (473 citations), Molecular Medicine (77 citations) and Pharmacology (78 citations). Yaqi Lv has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Lifang Yin, Yiao Wang, Lifang Fan, Wei He, Jin Zhu, Chao Qin, Ke Yang, Shumin Zhu, Wei He and Chao Qin. Their work appears in journals such as International Journal of Pharmaceutics, Scientific Reports, BMC Medical Research Methodology, Clinical Chemistry and Laboratory Medicine (CCLM) and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.